pancreatic cancer Archives -

Halozyme abandons cancer R&D as lead drug failed

https://pharmaphorum.com/news/halozyme-abandons-cancer-rd-as-lead-drug-failed/

Lilly’s $1.6bn cancer drug draws blank in pancreatic cancer trial

https://pharmaphorum.com/news/lillys-1-6bn-cancer-drug-draws-blank-in-pancreatic-cancer-trial/

AZ/Merck & Co wow ASCO with pancreatic cancer data

https://pharmaphorum.com/news/az-merck-co-wow-asco-with-pancreatic-cancer-data/

Oncology round-up: AZ and Daiichi score key trial win with breast cancer antibody and more

https://pharmaphorum.com/views-and-analysis/oncology-round-up-az-and-daiichi-score-key-trial-win-with-breast-cancer-antibody-and-more/

CRUK tests drug combo for advanced pancreatic cancer

https://pharmaphorum.com/news/cruk-tests-drug-combo-for-advanced-pancreatic-cancer/

Clovis’ Rubraca is latest PARP drug showing promise in pancreatic cancer

https://pharmaphorum.com/news/clovis-rubraca/

AZ/Merck & Co’s Lynparza delays spread of pancreatic cancer

https://pharmaphorum.com/news/az-merck-cos-lynparza-delays-spread-of-pancreatic-cancer/

GSK begins clinical trials of pancreatic cancer combination

https://pharmaphorum.com/news/gsk-begins-clinical-trials-of-pancreatic-cancer-combination/

Lilly buys cancer biotech ARMO for $1.6bn

https://pharmaphorum.com/news/lilly-buys-cancer-biotech-armo-for-1-6bn/

Search